CQC Case Study: Ampersand’s MyIBD Care – Home Monitoring for Patients with IBD
Posted on 05 Aug 2019
The CQC is the independent regulator of health and social care in England. Their purpose is to make sure people are provided with safe, effective, and high-quality care. They have recently published a series of case studies about driving improvement through technology and MyIBD Care has been selected as a new Telemonitoring technology.
Selected as part of Government’s shortlist to help the most vulnerable & isolated digitally during the Covid19 outbreak
24 Apr 2020
Press Release: Ampersand Health x Simplyhealth
25 May 2022
The UK’s leading health and dental plan provider Simplyhealth, has announced it has invested in Ampersand, provider of digital therapies for inflammatory...
Insight Live: Public Sector
16 Feb 2021
We are attending Insight Live 2021 this coming March.
Ampersand Health Featured in Spoonie Magazine
20 May 2021
The article, titled: ‘Do More and Feel Better? Let’s Talk About Pacing.’ gave tips and advice for people living with chronic illnesses like inflammatory...
Researchers from Mount Sinai Conduct Study Including My IBD Care
20 Sep 2023
Researchers from Mount Sinai, one of the largest teaching hospitals in the US, conducted a study on digital support tools for people with IBD, including My IBD...
